CompletedNot Applicable

Turkish Validity and Reliability of the Bolus Residue Scale in Acute Stroke

Turkey (Türkiye)40 participantsStarted 2025-08-01

Plain-language summary

This study aims to evaluate the validity and reliability of the Turkish version of the Bolus Residue Scale (BRS) in patients with acute stroke. The study has a methodological, observational, and cross-sectional design. Videofluoroscopic swallowing study (VFSS) recordings will be scored independently by trained raters using the BRS. Psychometric properties including construct validity, criterion validity, inter-rater and intra-rater reliability will be analyzed.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of acute stroke confirmed by neurological and radiological evaluation * Age 18 years and older * Undergoing videofluoroscopic swallowing study (VFSS) as part of routine clinical assessment * Ability to participate in swallowing assessment procedures * Provision of written informed consent by the patient or a legal representative Exclusion Criteria: * History of head and neck cancer or head and neck surgery * Pre-existing neurological diseases affecting swallowing (e.g., Parkinson's disease, amyotrophic lateral sclerosis) * Structural abnormalities of the upper aerodigestive tract * Severe cognitive impairment preventing cooperation with assessment procedures * Incomplete or poor-quality VFSS recordings unsuitable for analysis

What they're measuring

Bolus Residue Scale (BRS)

Timeframe: Baseline (during videofluoroscopic swallowing study assessment)

Trial details

NCT IDNCT07435441

SponsorIstanbul Arel University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-15

View on ClinicalTrials.gov More Post-stroke trials